2026-2034年眼科受託研究機構（CRO）全球市場規模、佔有率、趨勢和成長分析報告

全球眼科合約研究組織（CRO）市場預計將從2025年的34億美元成長至2034年的70.5億美元，並預計在2026年至2034年間以8.44%的複合年成長率成長。該市場正經歷顯著成長，主要得益於針對眼科疾病和視力相關障礙的臨床研究活動的日益增多。眼科CRO提供臨床試驗管理、法規遵循、受試者招募和數據分析等專業服務。青光眼、白內障、糖尿病視網膜病變和老齡化黃斑部病變等疾病的日益普遍，推動了對創新治療方法的需求。製藥和生技公司擴大將研究活動外包，以提高效率並縮短研發週期。

眼科藥物和醫療設備研發的進步催生了對專業研究能力的強勁需求。合約研究組織 (CRO) 提供經驗豐富的研究人員、先進技術和全球臨床試驗網路，從而加速臨床開發。對生物製藥、基因療法和標靶眼科治療的投資增加，進一步推動了市場擴張。監管機構對全面臨床評估的要求也促進了與專業研究機構的合作。

隨著全球眼科疾病負擔持續加重，市場前景依然十分樂觀。新興治療方法、精準醫療方法和數位化臨床試驗技術將為市場參與企業創造更多機會。新興經濟體臨床研究活動的拓展預計將推動市場成長。隨著眼科領域創新不斷推進，合約研究組織（CRO）將在新治療方法上市過程中發揮日益重要的作用。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節提供清晰的市場概覽，包括關鍵定義、分類和當前產業格局。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭動態以及主要參與者所採取的策略。

市場預測：本預測是基於特定預測期內的市場規模和成長模式數據。本節結合歷史趨勢、當前市場狀況和定量分析，揭示未來預期趨勢。

區域分析：本部分全面回顧了主要地理區域的市場表現，確定了高成長領域和區域趨勢，從而更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的客製化服務，可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點或專注於特定細分市場的洞察，以更好地支持您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球眼科受託研究機構（CRO）市場：依服務類型分類

• 市場分析、洞察與預測
• 早期開發服務（臨床前試驗、藥物動力學 (PK) 和動態(PD) 研究、毒性研究、首次人體試驗 (FIH)、製劑開發）
• 臨床研究（I期試驗、II期試驗、III期試驗、IV期試驗（上市後監測）、設施管理、受試者招募及保留）
• 化驗服務（生物分析檢測、生物標記分析、中心實驗室服務、組織病理學、基因組學和蛋白​​質組學服務）
• 監管諮詢服務（制定監管策略、準備和提交臨床實驗藥物申請或臨床試驗申請、準備監管文件、支持與監管機構的會議以及提供標籤和合規性諮詢）

第5章：全球眼科受託研究機構（CRO）市場：依治療領域分類

• 市場分析、洞察與預測
• 傳統治療方法
• 抗發炎治療
• 皮質類固醇
• 非類固醇消炎劑
• 其他抗發炎療法
• 抗氧化療法
• 其他常規治療方法
• 先進治療方法

第6章 全球受託研究機構（CRO）市場：依最終使用者分類

• 市場分析、洞察與預測
• 製藥和生物製藥公司
• 醫療設備製造商
• 學術機構

第7章 全球受託研究機構（CRO）市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • IQVIA Holdings Inc
  • ICON Plc
  • Charles River Laboratories InternationalInc
  • Eurofins Scientific SE
  • Syneos HealthInc
  • Medpace HoldingsInc
  • WuXi AppTec Co.Ltd
  • Parexel International Corporation
  • Fortrea Holdings Inc
  • Laboratory Corporation Of America Holdings（Covance）
  • SGS SA（SGS Life Sciences）
  • PSI CRO AG
  • Worldwide Clinical Trials
  • Novotech Health Holdings Pty Limited
  • TFS HealthScience

The global ophthalmology contract research organization market size is expected to reach USD 7.05 Billion in 2034 from USD 3.40 Billion in 2025, growing at a CAGR of 8.44 during 2026-2034.This market is experiencing significant growth due to increasing clinical research activities focused on eye diseases and vision-related disorders. Ophthalmology contract research organizations provide specialized services for clinical trial management, regulatory support, patient recruitment, and data analysis. Rising prevalence of conditions such as glaucoma, cataracts, diabetic retinopathy, and age-related macular degeneration is driving demand for innovative therapies. Pharmaceutical and biotechnology companies are increasingly outsourcing research activities to improve efficiency and reduce development timelines.

Advancements in ophthalmic drug development and medical devices are creating strong demand for specialized research expertise. Contract research organizations offer access to experienced investigators, advanced technologies, and global trial networks that accelerate clinical development. Growing investments in biologics, gene therapies, and targeted ophthalmic treatments are further supporting market expansion. Regulatory requirements for comprehensive clinical evaluations are also encouraging partnerships with specialized research providers.

Future prospects remain highly favorable as the global burden of eye diseases continues to increase. Emerging therapies, precision medicine approaches, and digital clinical trial technologies will create additional opportunities for market participants. Expansion of clinical research activities in emerging economies is expected to strengthen market growth. As innovation in ophthalmology advances, contract research organizations will play an increasingly important role in bringing new treatments to market.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Service Type

• Early Phase Development Services (Preclinical Trials, Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, Toxicology Studies, First-In-Human (FIH) Studies, Formulation Development)
• Clinical Research (Phase I Trials, Phase II Trials, Phase III Trials, Phase IV (Post-Marketing Surveillance), Site Management, Patient Recruitment and Retention)
• Laboratory Services (Bioanalytical Testing, Biomarker Analysis, Central Laboratory Services, Histopathology, Genomic and Proteomic Services)
• Regulatory Consulting Services (Regulatory Strategy Development, Investigational New Drug or Clinical Trial Application Preparation and Submission, Regulatory Writing and Documentation, Health Authority Meeting Support, Labeling and Compliance Consulting)

By Therapy

• Traditional Interventions
• Anti-Inflammatory Interventions
• Corticosteroids
• Non-Steroidal Anti-Inflammatory Drugs
• Other Anti-Inflammatory Interventions
• Anti-Oxidative Interventions
• Other Traditional Interventions
• Advanced Interventions

By End User

• Pharma or Biopharma Companies
• Medical Device Companies
• Academic Institutes

COMPANIES PROFILED

• IQVIA Holdings Inc., ICON plc, Charles River Laboratories International, Inc., Eurofins Scientific SE, Syneos Health, Inc., Medpace Holdings, Inc., WuXi AppTec Co., Ltd., Parexel International Corporation, Fortrea Holdings Inc., Laboratory Corporation of America Holdings (Covance), SGS SA (SGS Life Sciences), PSI CRO AG, Worldwide Clinical Trials, Novotech Health Holdings Pty Limited, TFS HealthScience

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL OPHTHALMOLOGY CONTRACT RESEARCH ORGANIZATION MARKET: BY SERVICE TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Service Type
• 4.2. Early Phase Development Services (Preclinical Trials, Pharmacokinetics (PK) and Pharmacodynamics (PD) Studies, Toxicology Studies, First-In-Human (FIH) Studies, Formulation Development) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Clinical Research (Phase I Trials, Phase II Trials, Phase III Trials, Phase IV (Post-Marketing Surveillance), Site Management, Patient Recruitment and Retention) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Laboratory Services (Bioanalytical Testing, Biomarker Analysis, Central Laboratory Services, Histopathology, Genomic and Proteomic Services) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Regulatory Consulting Services (Regulatory Strategy Development, Investigational New Drug or Clinical Trial Application Preparation and Submission, Regulatory Writing and Documentation, Health Authority Meeting Support, Labeling and Compliance Consulting) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL OPHTHALMOLOGY CONTRACT RESEARCH ORGANIZATION MARKET: BY THERAPY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Therapy
• 5.2. Traditional Interventions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Anti-Inflammatory Interventions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Corticosteroids Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Non-Steroidal Anti-Inflammatory Drugs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Anti-Inflammatory Interventions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Anti-Oxidative Interventions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Other Traditional Interventions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Advanced Interventions Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL OPHTHALMOLOGY CONTRACT RESEARCH ORGANIZATION MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Pharma or Biopharma Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Medical Device Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL OPHTHALMOLOGY CONTRACT RESEARCH ORGANIZATION MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Service Type
  • 7.2.2 By Therapy
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Service Type
  • 7.3.2 By Therapy
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Service Type
  • 7.4.2 By Therapy
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Service Type
  • 7.5.2 By Therapy
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Service Type
  • 7.6.2 By Therapy
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL OPHTHALMOLOGY CONTRACT RESEARCH ORGANIZATION INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 IQVIA Holdings Inc
  • 9.2.2 ICON Plc
  • 9.2.3 Charles River Laboratories InternationalInc
  • 9.2.4 Eurofins Scientific SE
  • 9.2.5 Syneos HealthInc
  • 9.2.6 Medpace HoldingsInc
  • 9.2.7 WuXi AppTec Co.Ltd
  • 9.2.8 Parexel International Corporation
  • 9.2.9 Fortrea Holdings Inc
  • 9.2.10 Laboratory Corporation Of America Holdings (Covance)
  • 9.2.11 SGS SA (SGS Life Sciences)
  • 9.2.12 PSI CRO AG
  • 9.2.13 Worldwide Clinical Trials
  • 9.2.14 Novotech Health Holdings Pty Limited
  • 9.2.15 TFS HealthScience